CAH · 8-K · 20261105PR000042
Revenue Guidance and Outlook
CARDINAL HEALTH INC · 2026-11-05 · Importance 67 · Surprise 76 · In source text
Cardinal Health raised FY27 non-GAAP diluted EPS guidance to $12.80–$13.00 from $12.40–$12.60. The revised range represents 17%–19% growth from the FY26 ex-tariff-refund baseline and 14%–15% growth from reported FY26 results. The company raised Pharmaceutical and Specialty Solutions profit-growth guidance to 10%–12% and Other profit-growth guidance to 17%–20%; Other revenue-growth guidance increased to 12%–14%.
Key facts
- Fiscal 2027 Other revenue growth guidance was raised to 12%–14% from 11%–13%. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | — | Fiscal 2027 Other revenue growth guidance was raised to 12%–14% from 11%–13%. |